Source: SEC

Vergent received $3.8M in Debt Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

John Santini

CEO Approval Rating

88/100

Vergent is a Minnesota-based biotechnology company that designs and develops fluorescence molecular agents for surgical applications.